洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR1800014890】長者慢性肌骼痛症運動治療研究計劃

基本信息
登记号

ChiCTR1800014890

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2018-02-07

临床申请受理号

/

靶点

/

适应症

慢性肌骼痛症

试验通俗题目

長者慢性肌骼痛症運動治療研究計劃

试验专业题目

長者慢性肌骼痛症運動治療研究計劃

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

長者慢性肌骼痛症運動治療研究計劃

试验分类
试验类型

随机平行对照

试验分期

其它

随机化

1:1 randomization

盲法

Open label

试验项目经费来源

Health Care and Promotion Scheme, Food and Health Bureau, The Government of SAR

试验范围

/

目标入组人数

72

实际入组人数

/

第一例入组时间

1990-01-01

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

(i) community-dwelling older adults (age ≥65 years); and (ii) mobile over 10m with or without a walking aid; (iii) present of chronic musculoskeletal pain over the past month and for at least 3 month of the previous year; (iv) pain intensity score ≥ 3 on a numerical rating scale of 10; (v) stable baseline activity; (vi) able to understand written and verbal Chinese.;

排除标准

(i) dementia or mild cognitive impairment (including those showing any signs of cognitive impairment as advised by the scheme manager/medical records); (ii) MSK pain due to uncontrolled rheumatic disease ; (iii) a recent self-reported history of stroke or major surgery (in the past 6 months); (iv) terminally ill; (v) has a serious mental illness; (vi) comorbid conditions which might interfere with the participant's active participation in the study; (vii) severe or uncontrolled heart disease; (viii) participants with major joint replacement or spinal surgery; and (ix) participants who fulfil the diagnostic criteria of Chronic Fatigue Syndrome (CFS) by the Center of Disease Control, which is a debilitating and complex disorder characterized by intense fatigue, which worsens with physical and mental exertion, with widespread pain as one of its presentations.;

研究者信息
研究负责人姓名
试验机构

The Chinese University Of Hong Kong

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

The Chinese University Of Hong Kong的其他临床试验

Division of Family Medicine and Primary Health Care, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品